Skip to main content

Dr. Steven Vasilev Named to Super Doctors 2026 for Southern California

Lotus Endometriosis Institute announces Dr. Steven Vasilev has been recognized as a Super Doctor for Southern California in 2026, reflecting peer-validated surgical expertise in complex endometriosis care and advanced pelvic disease management.

-- Lotus Endometriosis Institute has announced that its director and lead surgeon, Dr. Steven Vasilev, has been recognized as a Super Doctor for Southern California in 2026. The distinction reflects peer-validated surgical expertise in complex endometriosis care, a credential that matters when patients face advanced disease, multi-organ involvement, or repeat surgery scenarios. Super Doctors identifies approximately the top 5% of physicians in a region through a rigorous selection process that cannot be purchased, positioning the recognition as meaningful external validation in a specialty where many practitioners advertise endometriosis expertise.

The selection process behind the recognition involves peer nominations, independent research evaluating professional achievement across ten indicators, and review by a Blue Ribbon Panel composed of highly scored nominees within each specialty. Physicians cannot pay to be included, preserving the list's credibility as third-party validation rather than marketing placement. Because the list is refreshed annually, inclusion reflects current, earned recognition rather than a one-time designation.

Dr. Vasilev brings a unique credential set to the treatment of advanced pelvic disease. He holds quadruple board certifications in OB-GYN, Gynecologic Oncology, Integrative Medicine, and Holistic Medicine—a combination held by no other physician in the United States. With over 30 years of experience in minimally invasive gynecologic surgery and more than 20 years on national Best Doctors listings, his qualifications address the specific concerns of patients navigating complex or repeat-surgery cases that other centers may deem inoperable.

These credentials translate directly into clinical practice at Lotus Endometriosis Institute, where the exclusive focus is on complex endometriosis and related pelvic diseases. The institute routinely manages cases involving bowel, bladder, ureters, and pelvic nerves using advanced minimally invasive oncologic surgery techniques, addressing scenarios that other centers might decline. This specialization responds to the gaps patients face when seeking care, grounding the practice in the clinical reality that outcomes in complex cases depend on surgical planning, technical depth, and decision-making under uncertainty.

For patients evaluating surgical options, independent validation provides an external signal that cuts through marketing noise. The recognition reflects peer visibility and professional confidence—a proxy for referral trust and clinical judgment that becomes especially relevant when navigating advanced surgery, repeat surgery, or multi-organ involvement. Patients need indicators beyond marketing language, and structured peer recognition offers one such measure when assessing which surgeon has the depth and breadth to handle multi-organ complexity safely.

Patients seeking expert evaluation for suspected or confirmed endometriosis, those dealing with persistent symptoms after prior surgery, and individuals navigating complex disease can contact the institute at (424) 255-1340. The practice maintains locations in Santa Monica and Arroyo Grande, California, offering evaluation, surgical planning, and integrative support services designed to address the whole person and the full arc of treatment.

Visit https://lotusendo.com to learn more about scheduling and care options.

Contact Info:
Name: Dr. Steven Vasilev
Email: Send Email
Organization: Lotus Endometriosis Institute
Address: 154 Traffic Way, Arroyo Grande, CA 93420, United States
Website: https://lotusendo.com

Source: PressCable

Release ID: 89180952

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  236.65
+0.00 (0.00%)
AAPL  259.96
+0.00 (0.00%)
AMD  223.60
+0.00 (0.00%)
BAC  52.48
+0.00 (0.00%)
GOOG  336.31
+0.00 (0.00%)
META  615.52
+0.00 (0.00%)
MSFT  459.38
+0.00 (0.00%)
NVDA  183.16
+0.02 (0.01%)
ORCL  193.61
+0.00 (0.00%)
TSLA  439.20
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.